168 related articles for article (PubMed ID: 7957075)
1. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
[TBL] [Abstract][Full Text] [Related]
2. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
[TBL] [Abstract][Full Text] [Related]
3. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance mechanisms of mutant EF-Tu species in Escherichia coli.
Kraal B; Zeef LA; Mesters JR; Boon K; Vorstenbosch EL; Bosch L; Anborgh PH; Parmeggiani A; Hilgenfeld R
Biochem Cell Biol; 1995; 73(11-12):1167-77. PubMed ID: 8722034
[TBL] [Abstract][Full Text] [Related]
5. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
Pingoud A; Block W; Urbanke C; Wolf H
Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
[TBL] [Abstract][Full Text] [Related]
6. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
[TBL] [Abstract][Full Text] [Related]
7. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
8. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.
Hall CC; Watkins JD; Georgopapadakou NH
Antimicrob Agents Chemother; 1991 Nov; 35(11):2366-70. PubMed ID: 1839491
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.
Parmeggiani A; Krab IM; Okamura S; Nielsen RC; Nyborg J; Nissen P
Biochemistry; 2006 Jun; 45(22):6846-57. PubMed ID: 16734421
[TBL] [Abstract][Full Text] [Related]
11. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
12. Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevis.
Wörner W; Wolf H
FEBS Lett; 1982 Sep; 146(2):322-6. PubMed ID: 6890473
[TBL] [Abstract][Full Text] [Related]
13. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
Abdulkarim F; Liljas L; Hughes D
FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
[TBL] [Abstract][Full Text] [Related]
14. Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA.
Wolf H; Assmann D; Fischer E
Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5324-8. PubMed ID: 364475
[TBL] [Abstract][Full Text] [Related]
15. EF-Tu from the enacyloxin producing Frateuria W-315 strain: Structure/activity relationship and antibiotic resistance.
Créchet JB; Malosse C; Hountondji C
Biochimie; 2016 Aug; 127():59-69. PubMed ID: 27126073
[TBL] [Abstract][Full Text] [Related]
16. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879.
Landini P; Bandera M; Soffientini A; Goldstein BP
J Gen Microbiol; 1993 Apr; 139(4):769-74. PubMed ID: 8515234
[TBL] [Abstract][Full Text] [Related]
18. New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu.
Anborgh PH; Parmeggiani A
EMBO J; 1991 Apr; 10(4):779-84. PubMed ID: 2009857
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of elongation factor Tu. The functional and structural role of residue Cys81.
Anborgh PH; Parmeggiani A; Jonák J
Eur J Biochem; 1992 Sep; 208(2):251-7. PubMed ID: 1521523
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.
Tubulekas I; Hughes D
J Bacteriol; 1993 Jan; 175(1):240-50. PubMed ID: 8416899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
